IRVINE, Calif., Nov. 12, 2024 /CNW/ -- Zymo Research Corporation (Zymo Research), a leader in innovative life science solutions, announced today that it has filed claims in the United District Court for the Central District of California against Qiagen GmbH (Qiagen) alleging that Qiagen has engaged in antitrust violations and improperly interfered with Zymo Research's contractual relations. These claims were filed as part of an amended response to a patent infringement lawsuit previously filed by Qiagen. In addition to asserting its claims for antitrust and interference, Zymo Research's amended response denies all of Qiagen's allegations of infringement.
Read more at newswire.caZymo Research Fights Back Against Qiagen's Lawsuit, Asserts Antitrust Violations and Attempts to Stifle Innovation
Newswire.ca - Press Release
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here